Streetbeat News

ACGN

Aceragen Inc

http://www.iderapharma.com/

CEO

Vincent Milano

Industry

Biological Product (except Diagnostic) Manufacturing

idera pharmaceuticals is a clinical stage biotechnology company with expertise in discovering, developing and commercializing novel nucleic acid therapeutics to treat patients with serious and life-threatening diseases. idera is focused on harnessing the potential of our proprietary technology to treat genetically defined forms of b-cell lymphomas and rare autoimmune diseases.

Open

0.43

Mkt cap

3.2M

Volume

53K

High

0.38

P/E Ratio

-0.04

52-wk high

16.00

Low

0.38

Div yield

N/A

52-wk low

0.36

In Wednesday's after-market session, several healthcare stocks saw significant movement. Vistagen Therapeutics, AIM ImmunoTech, Tenon Medical, Virpax Pharmaceuticals, PMV Pharma, and LogicMark saw gains ranging from 9.31% to 22.5%. On the other hand, Galera Therapeutics, Organogenesis Hldgs, Matinas BioPharma Hldgs, Infinity Pharmaceuticals, Akso Health Group, and Aceragen saw declines ranging from 9.3% to 83.2%.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 9:32 pm

During Monday's intraday session, several healthcare stocks experienced significant movements. Vistagen Therapeutics, Nektar Therapeutics, Tabula Rasa HealthCare, Poseida Therapeutics, Enveric Biosciences, and Palatin Techs saw their shares rise, with Vistagen Therapeutics leading the gainers with an 871.4% increase. On the other hand, Sage Therapeutics, Tivic Health Systems, Aceragen, Quantum-Si, Infinity Pharmaceuticals, and BIMI Intl Medical saw their shares fall, with Sage Therapeutics leading the losers with a 52.3% decrease.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 5:31 pm

The article lists the stocks that gained and lost the most during Monday's mid-day trading session. Among the gainers were Vistagen Therapeutics, Save Foods, Poseida Therapeutics, and Missfresh Limited, all of which saw significant jumps in their share prices due to various positive developments. On the other hand, Sage Therapeutics, Tivic Health Systems, Yellow Corporation, and Quantum-Si incorporated were among the biggest losers, with their shares tumbling due to negative news such as worse-than-expected results and regulatory setbacks.

Portfolio Pulse from Lisa Levin

August 07, 2023 | 5:28 pm

Aceragen, Inc. (NASDAQ:ACGN) announced its plans to delist from the Nasdaq, leading to a 30% drop in its stock price. The delisting process will be orderly and subject to stockholder approval at a special meeting scheduled for August 14. The company is also seeking stockholder approval for a transfer and assignment of most of its assets to an assignee for the benefit of creditors.

Portfolio Pulse from Henry Khederian

August 07, 2023 | 2:34 pm

Aceragen announced its decision to delist from the Nasdaq, leading to a drop in its share prices.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 1:10 pm

Several healthcare stocks experienced significant movement in Monday's pre-market session. Vistagen Therapeutics, Nektar Therapeutics, Tabula Rasa HealthCare, T2 Biosystems, Gracell Biotechnologies, and Protalix BioTherapeutics saw increases, while Sage Therapeutics, Tivic Health Systems, Aceragen, Quantum-Si, Apellis Pharmaceuticals, and HUTCHMED (China) saw declines. Q2 earnings were released for several of these companies.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 1:05 pm

Several stocks experienced significant pre-market trading movements. Notable gainers include Save Foods, Inc. (SVFD), Missfresh Limited (MF), AgriFORCE Growing Systems Ltd. (AGRI), BYND Cannasoft Enterprises Inc. (BCAN), and Kosmos Energy Ltd. (KOS). Major losers include Tivic Health Systems, Inc. (TIVC), Yellow Corporation (YELL), Aceragen, Inc. (ACGN), Tempo Automation Holdings, Inc. (TMPO), and iBio, Inc. (IBIO).

Portfolio Pulse from Lisa Levin

August 07, 2023 | 12:07 pm

In Friday's after-market session, several health care stocks experienced significant movement. Gainers included Akso Health Group (AHG), T2 Biosystems (TTOO), MSP Recovery (LIFW), Context Therapeutics (CNTX), Soligenix (SNGX), and Sonendo (SONX). Losers included Tivic Health Systems (TIVC), Aceragen (ACGN), Biodexa Pharmaceuticals (BDRX), Trxade Health (MEDS), iBio (IBIO), and TC BioPharm (TCBP).

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 9:32 pm

Aceragen, Inc. (NASDAQ:ACGN) has announced its intention to voluntarily delist from the Nasdaq Capital Market by filing a Form 25 with the SEC around August 15, 2023. This follows a special meeting on August 14, 2023, where the company will seek stockholder approval to transfer and assign most of its assets to an assignee for the benefit of creditors.

Portfolio Pulse from Happy Mohamed

August 04, 2023 | 8:31 pm

In Thursday's pre-market session, several healthcare stocks saw significant movement. Mallinckrodt (MNK), Femasys (FEMY), Lipocine (LPCN), Cutera (CUTR), Align Tech (ALGN), and Lixte Biotech Hldgs (LIXT) shares rose, with Align Tech's rise potentially linked to their Q2 earnings report. Meanwhile, Mersana Therapeutics (MRSN), Biohaven (BHVN), icad (ICAD), Aceragen (ACGN), PaxMedica (PXMD), and Spruce Biosciences (SPRB) shares fell.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 1:06 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.